

Dear Colleagues
It is a real pleasure to welcome you the 7th Christmas Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.
Monday , December 11th (UK Time) | Tuesday, December 12th (UK Time) | ||
---|---|---|---|
8:30 -09:45 | Welcome Address Opening Lectures
|
8:30-10:30 | Session 4 Arrhythmias and SCD
|
9:45-10:15 | Coffee | 10:30-11:00 | Coffee |
10:15-12:30 | Session 1 Risk Factors and Prevention Guidelines
|
11:00-12:30 | Session 5 Structural Heart Disease
|
12:30-13:15 | Industry Sponsored Session | 12:30-13:15 | Industry Sponsored Session |
13:15-14:00 | Lunch Break | 13:15-14:00 | Lunch Break |
14:00-16:00 | Session 2 Acute and Chronic Coronary Syndromes
|
14:00-14:30
|
The Paul Hamilton Wood Lecture |
14:30-15:45 |
Session 6
|
||
16:00-16:30 | Coffee | 15:45-16:15 | Coffee |
16:30-18:30 | Session 3 The ESC 2023 Guidelines
|
16:15-17:15 | Session 7 Cardiorenal Syndrome Cardiomyopathies
|
18:30-20:00 | Networking Reception | 17:15 | Adjourn |
Venue: The Royal Society of Medicine
08:30-09:00 | Welcome Address | |||||
08:30 | Welcome by the ESC President: The future of Cardiology in Europe |
Thomas F. Lüscher, London |
08:45 - 09:45 | Opening Lectures: Frontiers in Cardiovascular Science Chair: Thomas F. Lüscher, London and Filippo Crea, Rome |
||
08:45 | Opening Lectures 1: Lipoprotein (a) a risk factor for CAD and aortic stenosis? |
Hugh Watkins, Oxford |
09:15 | Opening Lecture 2: Digital health in current clinical practice |
Lale Tokgözoğlu, Ankara |
09:45- 10:15 COFFEE BREAK |
10:15 - 12:30 | Session 1: Risk Factors and Prevention Chairs: Mahmoud Barbier, Harefield and NN |
||
10:15 | Is targeting inflammation ready for prime time? | Peter Libby, Boston |
10:35 |
Development of nucleic-acid based therapies to |
Ulf Landmesser, Berlin |
10:55 | Novel antilipidaemic drugs: : CLEAR and clinical practice | Kausik Ray, London |
11:15 | The 2023 ESC Guidelines on Cardiovascular Disease and Diabetes | Nikolaus Marx, Aachen |
11:35 | Obesity: New options for an epidemiological challenge | Naveed Sattar, Glasgow |
11:55 | Panel Discussion | All |
12:30 - 13:15 | Industry sponsored symposium | ||
13:15-14:00 Lunch Buffet |
14:00 - 16:15 | Session 2: Acute and Chronic Coronary Syndromes Chairs: Richard Grocott-Mason, London and Peter Libby, Boston |
||
14:00 | Intracoronary imaging and clinical outcomes | Lorenz Räber, Bern |
14:20 | ESC 2023 Guidelines on Acute Coronary Syndromes | Borja Ibáñez, Madrid |
14:40 | Challenges in PCI: high-risk and complex lesions (CHIP) | Jonathan Hill, London |
15:00 | Patient case TBD |
Mohammed Majid Akhtar, |
15:20 | From plaque rupture to erosion: A step towards precision medicine? | Filippo Crea, Rome |
15:40 | PCI for ischemic cardiomyopathy: The Revived Trial | Divaka Perera, London |
16:00 | Panel Discussion | |
16:15- 16:45 COFFEE BREAK |
16:45 - 17:15 | Industry sponsored symposium |
17:15 - 18:45 | Session 3: Practical Implications of the new ESC 2023 Guidelines Chairs: NN and NN |
||
17:15 | Cardiomyopathies | Juan Pablo Kaski, London |
17:30 | Q&A | |
17:40 | Endocarditis | Victoria Delgado, Badalona |
17:55 | Q&A | |
18:15 Cross-functional Networking Reception |
Venue: The Royal Society of Medicine
08:30 - 10:30 | Session 4: Arrhythmias, Sudden Cardiac Death Chairs: NN and NN |
||
08:30 | Pulse field ablation of atrial fibrillation: A revolution? | Gerhard Hindricks, Berlin |
08:50 | Upstream therapy for the prevention of AF: Is it realistic? | Bernard Gersh, Rochester |
09:10 | My patient with AF and ischemic heart disease | Shouvik Haldar, London |
09:30 | Cardiogenic shock and effect of assist devices | Susanna Price, London |
09:50 | Personalized indication for ICD? Genetics, fibrosis and LVEF | Lars Køber, Copenhagen |
10:10 | Panel discussion | All |
10:30-11:00 | COFFEE BREAK |
11:00- 12:45 | Session 5: Valvular Heart Disease Chairs: Miles Dalby, London and NN |
||
11:00 | Multimodality imaging in transcatheter aortic valve replacement | Jeroen J. Bax, Leiden |
11:20 | TAVI versus SAVR: moving indications? | Stephan Windecker, Berne |
11:40 | Secondary mitral regurgitation: Medication, TEER or surgery? | Francesco Maisano, Milano |
12:00 | TEER for tricuspid regurgitation: ILLUMINATE and beyond | Georg Nickenig, Bonn |
12:20 | Panel discussion |
12:30 - 13:15 | Industry Sponsored Symposium | ||
13:15-14:00 Lunch Buffet |
14:00 - 14:30 | The Paul Hamilton Wood Lecture Chairs: Bernard J. Gersh, Rochester MN and Thomas F. Lüscher, London |
14:30 - 15:45 | Session 6: Heart Failure: Established and Novel Drugs / Advanced Stage Chairs: Paul Kalra, Portsmouth and Giuseppe Rosano, London |
||
14:30 | Focused update on the 2021 ESC HF Guidelines | Theresa McDonagh, London |
14:50 | HFpEF: From hemodynamics to management | Barry Borlaug, Rochester |
15:10 | Iron deficiency in heart failure | Paul Kalra, Portsmouth |
15:30 | Panel discussion | |
15:45 - 16:00 COFFEE BREAK |
16:00 - 17:15 | Session 7: Heart, Kidney and Amyloidosis Chairs: NN and NN |
||
16:00 | Is LVEF still important for HF management? | John McMurray. Glasgow |
16:20 | The cardiorenal axis: new treatment targets | David C. Wheeler, London |
16:40 | Cardio-oncology: What is the evidence today? | Sohaib Nazir, London |
17:00 | Panel discussion | |
17:15 | Wrap-up and Adjourn | Thomas F. Lüscher, London |
Updated: 12.05.2023
Category | |
---|---|
Registration fees | |
Regular fee | GBP 300 |
Early registration fee (until November 10, 2023) | GBP 250 |
ESC / Association Members | |
Regular fee | GBP 250 |
Early registration fee (until November 10, 2023) | GBP 200 |
Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)* | |
Regular fee | GBP 150 |
Early registration fee (until November 10, 2023) | GBP 100 |
Day Ticket | GBP 150 |
Group Registration (For group registrations a minimum of 10 participants is required)** | |
Regular fee | GBP 260 |
Early registration fee (until November 10, 2023) | GBP 210 |
*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Nadine-Estelle Abea at nadine-estelle.abea@zhh.ch.
**Please contact Ms. Nadine-Estelle Kaltheuner (nadine-estelle.kaltheuner@zhh.ch) at the Zurich Heart House to obtain further information.
Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.
Modification & Cancellation
All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to the Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancel-lation up to 1st of November 2023, deposits will be refunded less 35 % for administrative costs. After this date, no refund will be possible.
Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Nadine-Estelle Abea
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90